CONTENTS 8 Reaching out: BIO abroad
For the Biotechnology Industry Organization, key developing markets pose particular challenges in terms of intellectual property and also in a wider context. LSIPR spoke to Joe Damond and Lila Feisee about international affairs.
14 Out in front: the Boston Cluster
When it comes to life sciences, Boston is out on its own. LSIPR takes a look at innovation in the Olde Towne.
8 18 A new framework: challenging patents in changing times
The America Invents Act was signed into law in September 2011, and many biotech companies are still trying to make sense of the new legislation. Eldora Ellison and Eric Steffe consider one of the most important changes.
22 Formal obligations: burdens on biotech patents
Although the patentability of biotechnological inventions as described in a European patent application should meet substantive requirements such as novelty, inventive step and industrial applicability, latest developments at the European Patent Office suggest that formalities have become more and more important, say Caroline Pallard and Peter ten Haaft.
18
26 A brave new world for supplementary protection certificates?
Advocate-General Verica Trstenjak has delivered an opinion in the case of Neurim Pharmaceuticals that, if followed by the Court of Justice of the EU, will profoundly liberalise the law governing SPCs in Europe. Mike Snodin and Michael Pears report.
30 Is there life for medical diagnostic patents after Prometheus?
30
The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong explains.
4
Life Sciences Intellectual Property Review 2012
www.worldipreview.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64